SCHEMBL874930

SCHEMBL874930

O=P(O)(O)c1c[nH]nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20738445 0.76
Phosphoric Acid SCHEMBL7209022 0.70
SCHEMBL22666306 0.69
SCHEMBL20738444 0.67 ALDH1A1 (0.32)
SCHEMBL12050690 0.67 PGK1 (0.45)
SCHEMBL20738496 0.64
SCHEMBL1400937 0.62
SCHEMBL4800548 0.62
SCHEMBL9353824 0.62 MMP1 (0.33)
SCHEMBL20379780 0.60 CA2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115633699-A Application of fully-substituted 1,2, 3-triazole-4-phosphonate compound in preparation of antibacterial drugs 河南师范大学 2023-01-24 CN claimed
EP-0101985-B1 OLIGONUCLEOTIDE DERIVATIVES AND PRODUCTION THEREOF WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1987-09-23 EP claimed
EP-0101985-A1 Oligonucleotide derivatives and production thereof WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1984-03-07 EP claimed
US-12624358-B2 Compounds and methods for reducing PLN expression IONIS PHARMACEUTICALS, INC. (US) 2026-05-12 US disclosed
EP-3452049-B1 GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF IONIS PHARMACEUTICALS INC (US) 2026-04-01 EP disclosed
EP-4704858-A1 SUGAR MODIFIED OLIGONUCLEOTIDES AND USES THEREOF Ionis Pharmaceuticals, Inc. (US) 2026-03-11 EP disclosed
WO-2026044046-A1 PATTERNED MODIFIED OLIGONUCLEOTIDES FOR EXTENDED DURATION OF ACTION IONIS PHARMACEUTICALS, INC. (US) 2026-02-26 WO disclosed
WO-2026043966-A1 COMPOUNDS AND METHODS FOR MODULATING ALPHA-SYNUCLEIN EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2026-02-26 WO disclosed
EP-4689119-A1 COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2026-02-11 EP disclosed
EP-4673453-A1 DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND METHODS RELATING THERETO Wave Life Sciences Ltd. (SG) 2026-01-07 EP disclosed
US-20250382617-A1 DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND METHODS RELATING THERETO WAVE LIFE SCIENCES LTD. (SG) 2025-12-18 US disclosed
EP-0625873-B1 PHOSPHONIC ACID DERIVATIVES CONTAINING A TRIAZOLE RING AS HERBICIDES ZENECA LTD (GB) 1997-11-05 EP disclosed
EP-0730408-A1 TRIAZOLE PHOSPHONATE PESTICIDES AgrEvo UK Limited (GB) 1996-09-11 EP disclosed
EP-0730408-A1 TRIAZOLE PHOSPHONATE PESTICIDES AgrEvo UK Limited (GB) 1996-09-11 EP disclosed
WO-1995014385-A1 TRIAZOLE PHOSPHONATE PESTICIDES AGREVO UK LIMITED (GB) 1995-06-01 WO disclosed
WO-1995014385-A1 TRIAZOLE PHOSPHONATE PESTICIDES AGREVO UK LIMITED (GB) 1995-06-01 WO disclosed
US-5393732-A Triazole phosphoric acid derivatives and their use as herbicides ZENECA LIMITED (GB) 1995-02-28 US disclosed
EP-0625873-A1 PHOSPHONIC ACID DERIVATIVES CONTAINING A TRIAZOLE RING AS HERBICIDES ZENECA LIMITED (GB) 1994-11-30 EP disclosed
WO-1993015610-A1 PHOSPHONIC ACID DERIVATIVES CONTAINING A TRIAZOLE RING AS HERBICIDES ZENECA LIMITED (GB) 1993-08-19 WO disclosed
US-4401796-A PHOSPHORYLATION OF A NUCLEOSIDE TO OBTAIN A MONOTRIAZOLIDE; REACTING WITH A MODIFIED RESIN SUPPORT; HYDROLYSIS CITY OF HOPE RESEARCH INSTITUTE (US) 1983-08-30 US disclosed